Related references
Note: Only part of the references are listed.Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation
David J. Seiffge et al.
ANNALS OF NEUROLOGY (2019)
Anticoagulation After Stroke in Patients With Atrial Fibrillation: To Bridge or Not With Low-Molecular-Weight Heparin?
Riccardo Altavilla et al.
STROKE (2019)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline
Catharina J. M. Klijn et al.
EUROPEAN STROKE JOURNAL (2019)
Direct oral anticoagulants in the early phase of non-valvular atrial fibrillation-related ischemic stroke in very old patients undergoing systemic thrombolysis and/or mechanical thrombectomy
Luca Masotti et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2018)
Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials
George Ntaios et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study
Maurizio Paciaroni et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Rivaroxaban vsWarfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke A Randomized Clinical Trial
Keun-Sik Hong et al.
JAMA NEUROLOGY (2017)
Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study)
Naoki Saji et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
Mayank Goyal et al.
LANCET (2016)
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis
William N. Whiteley et al.
LANCET NEUROLOGY (2016)
Early start of DOAC after ischemic stroke Risk of intracranial hemorrhage and recurrent events
David J. Seiffge et al.
NEUROLOGY (2016)
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Hein Heidbuchel et al.
EUROPACE (2015)
Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke
T. Ritzenthaler et al.
REVUE NEUROLOGIQUE (2015)
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Effect of Anticoagulation and Its Timing: The RAF Study
Maurizio Paciaroni et al.
STROKE (2015)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Share Paper
